Imricor Medical Systems Valuation
Is IMR undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of IMR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate IMR's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate IMR's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IMR?
Other financial metrics that can be useful for relative valuation.
| What is IMR's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$62.67m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 117.3x |
| Enterprise Value/EBITDA | -4.5x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does IMR's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 3.1x | ||
OIL Optiscan Imaging | 4.2x | n/a | AU$69.3m |
CVB CurveBeam AI | 1.3x | 90.1% | AU$59.2m |
EYE Nova Eye Medical | 3.6x | 102.3% | AU$61.8m |
IPD ImpediMed | 3.2x | 38.1% | AU$161.8m |
IMR Imricor Medical Systems | n/a | 36.4% | AU$95.2m |
Price-To-Book vs Peers: IMR has negative equity and a Price-To-Book Ratio (-7.2x) compared to the peer average (3.1x).
Price to Earnings Ratio vs Industry
How does IMR's PE Ratio compare vs other companies in the AU Medical Equipment Industry?
Price-To-Book vs Industry: IMR has negative equity and a Price-To-Book Ratio (-7.2x) compared to the Australian Medical Equipment industry average (4.1x).
Price to Book Ratio vs Fair Ratio
What is IMR's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | -7.2x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate IMR's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.